Skip to main content

Want a detailed portfolio tracker?

Exicure (XCUR) P/E (2018 - 2026)

Exicure (XCUR) P/E from May 22, 2018 to Jun 3, 2026. The TTM Exicure (XCUR) P/E is -6.95. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Exicure (XCUR)

YearP/EChange
2026-6.95-41.70%
2025-11.91+3.82%
2024-11.47+140.47%
2023-4.77-68.22%
2022-15.02-81.03%
2021-79.17-88.58%
2020-693.35-38.11%
2019-1.12K+12.97%
2018-991.75N/A

Comparison Exicure (XCUR) P/E with competitors

Exicure (XCUR) P/E is -6.95.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.47%
ENLVEnlivex Therapeutics Ltd0.15-102.16%
FGENFibroGen Inc0.24-103.46%
TRAWTraws Pharma Inc0.47-106.81%
FBIOFortress Biotech Inc0.71-110.17%
CHRSCoherus Biosciences Inc0.98-114.08%
ORMPOramed Pharmaceuticals Inc1.47-121.21%
AGENAgenus Inc2.05-129.49%
VIVSVivoSim Labs Inc2.54-136.51%
INVAInnoviva Inc3.19-145.91%
CRMDCorMedix Inc3.65-152.49%
ABEOAbeona Therapeutics Inc4.20-160.54%
VXRTVaxart Inc4.26-161.36%
CVACCureVac N.V.4.45-164.01%
SRPTSarepta Therapeutics Inc4.62-166.58%
GLPGGalapagos NV4.86-169.96%
RIGLRigel Pharmaceuticals4.92-170.83%
ZVRAZevra Therapeutics Inc4.97-171.61%
ABUSArbutus Biopharma Corp5.69-181.98%
CGENCompugen Ltd7.38-206.31%
AUPHAurinia Pharmaceuticals Inc9.25-233.20%
ACADAcadia Pharmaceuticals Inc9.59-238.05%
OMEROmeros Corporation9.88-242.30%
PLXProtalix BioTherapeutics Inc9.91-242.67%
SPROSpero Therapeutics Inc10.73-254.56%
ADMAAdma Biologics Inc11.33-263.14%
SVASinovac Biotech Ltd11.44-264.66%
TBPHTheravance Biopharma Inc11.78-269.56%
HRMYHarmony Biosciences Holdings Inc12.18-275.37%
TGTXTG Therapeutics Inc13.18-289.76%
INCYIncyte Corp13.38-292.67%
SABSSAB Biotherapeutics Inc14.06-302.40%
XOMAXOMA Corp14.95-315.18%
REGNRegeneron Pharmaceuticals Inc14.98-315.69%
PBYIPuma Biotechnology Inc15.05-316.70%
EXELExelixis Inc15.79-327.41%
NAGENiagen Bioscience Inc16.35-335.48%
CPRXCatalyst Pharmaceuticals Inc17.34-349.73%
MDXGMimedx Group Inc17.38-350.17%
ARGXArgen X SE23.07-432.19%
HALOHalozyme Therapeutics Inc23.20-434.04%
XOMAOXOMA Corp25.34-464.91%
VRTXVertex Pharmaceuticals Inc25.66-469.39%
XOMAPXOMA Corp25.67-469.60%
CTMXCytomX Therapeutics Inc25.70-470.00%
ASNDAscendis Pharma A/S26.35-479.45%
RPRXRoyalty Pharma plc - Class A27.50-495.88%
SLNOSoleno Therapeutics Inc29.02-517.76%
LGNDLigand Pharmaceuticals Inc - Class B30.19-534.63%
BMRNBiomarin Pharmaceutical Inc37.51-640.03%
APLSApellis Pharmaceuticals Inc39.02-661.83%
KRYSKrystal Biotech Inc39.70-671.57%
GMABGenmab40.20-678.85%
ONCBeiGene Ltd67.03-1065.06%
TECHBio-Techne Corp68.59-1087.63%
VCELVericel Corp80.63-1260.90%
PHARPharming Group N.V.87.74-1363.29%
ALNYAlnylam Pharmaceuticals Inc124.93-1898.80%
TLXTelix Pharmaceuticals Ltd139.89-2114.15%
CORTCorcept Therapeutics Inc158.39-2380.50%